Skip to main content
SpringerLink
Log in

Aluminium-induced bone disease in uremic Rats: Effect of deferoxamine

  • Published:
Bioscience Reports

Abstract

We have previously established a rat model of chronic uremia, which is suitable to investigate the effect of various treatment modalities on renal osteodystrophy [1]. After four months subsequent to 5/6 nephrectomy, some animals were treated by gavage for 9 weeks with tap water (controls), or with aluminium (Al-citrate) 3 × 25 mg/week/kg b.wt ± subsequent deferoxamine (DFO) 3 × 50 mg/ week/kg b.wt. for 4 weeks. At termination of the study, serum clinical chemistry, femoral chemical composition and mechanical properties, calvarial parathyroid hormone (PTH)-elicited adenylate cyclase (AC) and phospholipase C (PLC) activities, cross-sectional femoral area, as well as bone histomorphometry, were analyzed. Animals given Al displayed moderately enhanced serum Al and bone Al accumulation, however, DFO-treatment did not fully alleviate bone Al retainment. A small increase in serum PTH was seen in all animals rendered uremic. Furthermore, a marked fall in serum alkaline phosphatase (ALP) below normal controls was observed in Al ± DFO-treated animals compared with uremic controls. The uremic condition led to reduced femoral ratios of hydroxyproline (HYP) over Ca2+ and phosphate (Pi), while Al-intoxication alone enhanced femoral Hyp contents above values seen for normal controls. The protracted ureamia caused a deterioration of long bone resilience and brittleness, however, Al ± DFO-treatment seemed to normalize the latter. Contrastingly, Al ± DFO-gavage enhanced time to fracture. Uremic rats intoxicated with Al showed a complete loss of calvarial PTH-sensitive AC and PLC activities. DFO-treatment normalized PTH-elicited PLC, while PTH-susceptible AC remained super-normal. Al apparently exerts a long term down-regulation of both PTH-sensitive signaling systems as evidenced by studies of rat UMR 106 osteosarcoma cells in culture. The uremic condition enhanced endosteal bone resorption as shown by femoral shaft dimension analysis, while AI ± DFO-treatment insignificantly reversed the condition. Finally, histomorphometrical analyses showed that DFO-administration tended to normalize aberrant trabecular bone volume, while rectifying both bone resorption and degree of mineralization. In conclusion, we assert that Al-intoxication hampers both processes (i.e. formation and resorption) of bone turnover, and that DFO-treatment to a certain extent prevents the uremia- and Al-induced bone disease in rats.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Jablonski, G., Klem, K. H., Attramadal, A., Dahl, E., Ronningen, E., Gautvik, K. M., Haug, E. and Gordeladze, J. O. (1993) Surgically induced uremia in rats I: effect on bone strength and metabolism.Biosci Rep. 13:275–287.

    Google Scholar 

  2. Ward, M. K., Feest, T. G., Ellis, H. A., Parkinson, I. S. and Kerr, D. N. S. (1978) Osteomalacic dialysis: evidence for a water-borne aetologic agent, aluminum.Lancet 1:841–845.

    Google Scholar 

  3. Parkinson, I. S., Ward, M. K. and Kerr, D. N. S. (1981) Dialysis encephalopathy, bone disease, and anaemia: The aluminum intoxication syndrome during regular haemodialysis.J. Clin Pathol. 34:1285–1294.

    Google Scholar 

  4. Touam, M., Martinez, F., Lacour, B., Bourdon, R., Zingraff, J., Diguilio, S. and Drueke, T. (1983) Aluminum-induced reversible microcytic anemia in chronic renal failure: Clinical and experimental studies.Clin. Neprhol. 19:295–298.

    Google Scholar 

  5. Llach, F., Felsenfeld, A. J., Coleman, M. D., Keveney, J. J., Jr., Pederson, J. A. and Medlock, T. R. (1986) The natural cause of dialysis osteomalacia.Kidney Int. 29:S74-S79.

    Google Scholar 

  6. Salusky, I. B., Coburn, J. W., Paunier, L., Sherrard, D. J. and Fine, R. N. (1984) Role of alumin hydroxide in raising serum aluminum levels in children undergoing CAPD.J. Pediatr 105:717–720.

    Google Scholar 

  7. Kaye, M. (1983) Oral aluminum toxicity in a non-dialyzed patient with renal failure.Clin. Neprol. 20:208–211.

    Google Scholar 

  8. Sideman, S. and Manor, D. (1982) The dialysis dementia syndrome and aluminum intoxication.Nephron. 31:1–10.

    Google Scholar 

  9. Fleming, L. W., Stewart, W. K., Fell, G. S. and Halls, D. J. (1982) The effect of oral aluminum therapy on plasma aluminum levels in patients with chronic renal failure in an area with low water aluminum.Clin. Neprhol. 17:222–227.

    Google Scholar 

  10. McKinney, T. D., Basinger, M., Dawson, E. and Jones, M. M. (1982) Serum aluminum levels in dialysis dementia.Nephron. 32:53–56.

    Google Scholar 

  11. Alfrey, A. C., Hegg, A. and Craswell, P. (1980) Metabolism and toxicity of aluminum in renal failure.Am. J. Clin. Nutr. 33:1509–1516.

    Google Scholar 

  12. Verbeelen, D., Smeyers-Verbeke, J., van Hooff, I. and de Roy, G. (1989) Vitamin D, desferrioxamine and aluminum-induced bone disease in uremic rats.Nephron 53:54–60.

    Google Scholar 

  13. Robertson, J. A., Felsenfeld, J., Haygood, C. C., Wilson, P., Clarke, C. and Llach, F. (1983) Animal model of aluminum-induced osteomalacia: role of chronic renal failure.Kidney Int. 23:327–335.

    Google Scholar 

  14. Chan, Y., Alfrey, A. C., Posen, S., Lissner, D., Hills, E., Dunstan, C. R. and Evans, R. A. (1983) Effect of aluminum on normal and uremic rats: tissue distribution, vitamin D metabolites, and quantitative bone histology.Calcif. Tissue Int. 35:344–351.

    Google Scholar 

  15. Halluche, H. H., Faugere, M. C., Friedler, R. M., Matthews, C. and Fanti, P. (1987) Calcitriol, parathyroid hormone and accumulation of Aluminium in bone in dogs with renal failure.J. Clin. Invest. 79(3):754–761.

    Google Scholar 

  16. Lieberherr, M., Grosse, B. and Cournot-Witmer, G.et al. (1987) Alumium action on mouse bone cell metabolism and response to PTH and 1,25(OH)2D3.Kidney Int. 31:736–743.

    Google Scholar 

  17. Alfrey, A. C., Sedman, A. and Chan, Y. L. (1986) The compartmentalization and metabolism of aluminum in uremic rats.J. Lab. Clin. Med. 105:318–324.

    Google Scholar 

  18. Goodman, W. G. (1987) Thyroparathryroidectomy modifies the skeletal response to aluminum loading in the rat.Kidney Int. 31:923–929.

    Google Scholar 

  19. Ellis, H. A., McCarthy, J. H. and Herrington, J. (1979) Bone aluminum in haemodialysis patients and in rats injected with aluminum chloride: Relationship to impaired mineralization.J. Clin. Pathol. 32:832–844.

    Google Scholar 

  20. Hirschberg, R., von Herrath, D., Voss, R., Bossaller, W., Mauelshagen, Pauls, A. and Schaefer, K. (1985) Organ distribution of aluminum in uremic rats: influence of parathyroid hormone and 1,25-dihydroxyvitamin D3.Mineral Electrolyte Metab. 11:106–110.

    Google Scholar 

  21. Burnatowska-Hledin, M. A., Doyle, T. M., Eadie, M. J. and Mayor, G. H. (1986) 1,25-Dihydroxyvitamin D3 increases serum and tissue accumulation of aluminum in rats.J. Lab. Clin. Med. 108(2):96–102.

    Google Scholar 

  22. Hodsman, H. B., Anderson, C. and Leung, F. Y. (1984) Accelerated accumulation of aluminum in rats.Miner Electrolyte Metab. 10:309–315.

    Google Scholar 

  23. Verbeelen, D., Smeyers-Verbeke, J., van Hoff, I. and de Roy, G. (1986) The effect of the desferrioxamine on concentration and distribution of aluminum in bone.Kidnev Int. 30:68–73.

    Google Scholar 

  24. Verbeelen, D., Smeyers-Verbeke, J., van Hooff, I. and de Roy, G. (1988) Placebo controlled study of the effect of desferriooxamine on tissue aluminum concentration and bone histology in aluminum-loaded rats with renal failure.J. Trace Elem. Health Dis. 2:67–72.

    Google Scholar 

  25. Malluche, H. H., Smith, A. J., Abreo, K. and Faugere, M. C. (1984) The use of deferoxamine in the management of aluminum accumulation in bone in patients with renal failure.New England Journal of Medicine 311(3):140–144.

    Google Scholar 

  26. Andress, D. L., Nebeker, H. G., Ott, S. M., Endres, D. B., Alfrey, A. C., Slatopolsky, E. A., Coburn, J. W. and Sherrard, D. J. (1987) Bone histologic response to deferoxamine in aluminum-related bone disease.Kidney Int. 31(6):1344–1350.

    Google Scholar 

  27. Brown, D. J., Dawborn, J. K., Ham, K. N. and Xipell, J. M. (1982) Treatment of dialysis ostemolacia with desferrioxamine.Lancet 2:343–345.

    Google Scholar 

  28. Lewis-Finch, J. L., Bergfeld, M., Martin, K. J., Chan, Y. L., Teitelbaum, S. and Slatopolsky, E. (1986) The effects of discontinuation of aluminum exposure on aluminum-induced osteomlacia.Kidney Int. 30:318–324.

    Google Scholar 

  29. Slanina, P., Falkeborn, Y., French, W. and Cedergren, A. (1984) Aluminum concentrations in the brain and bone of rats fed citric acid, aluminum citrate or aluminum hydroxide.Fd. Chem. Toxic 22(5):391–397.

    Google Scholar 

  30. Oftebro, H., Falch, J. A., Holmberg, I. and Haug, E. (1988) Validation of radioreceptor assay for 1,25-dihydroxyvitamin D using selected ion monitoring GC-MS.Clin. Chim. Acta 176:157–68.

    Google Scholar 

  31. Gautvik, K. M., Teig, V., Halvorsen, J. F., Arnesen, E., Myhre, L., Heimann, P. and Tollman, R. (1979) Development of sequence specific radioimmunoassay of human parathyroid hormone and its use in the diagnosis off hyperparathyroidism.Scand. J. Clin. Lab. Invest. 39:469–478.

    Google Scholar 

  32. van der Voet, G. B., de Haas, E. J. and de Wolff, F. A. (1985) Monitoring of aluminum in whole blood, plasma, serum and water by a single procedure using flameless atomic absorption spectrophotometry.J, Anal. Toxicol. 9(3):97–100.

    Google Scholar 

  33. Gordeladze, J. O., Halse, J., Djøseland, O. and Haugen, H. N. (1978) A simple procedure for determination of hydroxyproline in urine and bone.Biochem. Med. Metab. Biol. 20:23–30.

    Google Scholar 

  34. Gordeladze, J. O. and Gautvik, K. M. (1986) Hydroxycholecalciferols modulate parathyroid hormone and calcitonin sensitive adenylyl cyclase in bone and kidney of rats. A possible physiological role for 24,25-dihydroxy vitamin D3.Biochem. Pharmacol. 35(6):899–902.

    Google Scholar 

  35. Jackowski, S., Rettenmier, C. W., Sherr, C. J. and Rock, C. O. (1986) A guanine nucleotide-dependent phosphatidylinositol 4,5,-diphosphate phospholipase C in cells transformed by the v-fms and v-fes oncogenes.J. Biol. Chem. 261:24978–4985.

    Google Scholar 

  36. Engesater, L. B., Ekeland, A. and Langeland, N. (1978) Methods for testing the mechanical properties of the rat femur.Acta Orthop Scand. 49:512–518.

    Google Scholar 

  37. Danielsen, C. C., Mosekilde, Li and Andreassen, T. T. (1992) Long-term effect of orchidectomy on cortical bone from rat femur: bone mass and mechanical properties.Calcif Tissue Int. 50:169–174.

    Google Scholar 

  38. Danielsen, C. C., Mosekilde, Li and Svenstrup, B. (1993) Cortical bone mass, composition, and mechanical properties in female rats in relation to age, long-term ovariectomy, and estrogen substitution.Calcif. Tissue Int. 52:26–33.

    Google Scholar 

  39. Dahl, E., Nordal, K. P., Halse, J. and Attramadal, A. (1988) Histomorphometric analysis of normal bone from the iliac crest of Norwegian subjects.Bone Miner. 3:369–377.

    Google Scholar 

  40. Parfitt, A. M., Glorieux, F. H., Kanis, J. A., Malluche, H., Meunier, P. J., Ott, S. M. and Recker, R. R. (1987) Bone histomorphometry nomenclature, symbols and units. Report of the ASBMR Histomorphometry Nomenclature Committee.J. Bone Miner. Res. 2:595–610.

    Google Scholar 

  41. Felsenfeld, A. J., Machado, L., Bover, J., Trinidad, P. and Rodriguez, M. (1993) Effect of aluminium on the development of hyperparathyroidism and bone disease in the azotemic rat.Nephrol. Dial. Transplant 8(4):325–334.

    Google Scholar 

  42. Radunovic, A., Bradbury, M. W. and Delves, H. T. (1993) Determination of aluminium in different tissues of the rat by atomic absorption spectrometry with electrothermal atomization.Analyst 118(5):533–536.

    Google Scholar 

  43. Vick, K. E. and Johnson, C. A. (1985) Aluminum-related osteomalacia in renal-failure patients. [Review].Clin. Pharm. 4:434–439.

    Google Scholar 

  44. Maloney, N. A., Ott, S. M., Alfrey, A. C., Miller, N. L., Coburn, J. W. and Sherrard, D. J. (1982) Histological quantitation of aluminum in iliac bone from patients with renal failure.J. Lab. Clin. Med. 99:206–216.

    Google Scholar 

  45. Hodsman, A. B., Sherrard, D. J., Wong, E. G., Brickman, A. S., Lee, D. B., Alfrey, A. C., Singer, F. R., Norman, A. W. and Coburn, J. W. (1981) Vitamin-D-resistant osteomlacia in hemodialysis patients lacking secondary hyperparathyroidism.Ann. Intern. Med. 94:629–637.

    Google Scholar 

  46. Sherrard, D. J., Ott, S. M., Maloney, N. A., Andress, D. L. and Coburn, J. W. (1984) Uremic osteodystrophy: Classification, cause and treatment. In: Clinical Disorders of Bone and Mineral Metabolism,Exerpta Medica, Frame, B., Potts, J. T. (eds) Amsterdam: p. 254.

  47. Quartes, L. D. (1991) Paradoxical toxic and trophic osseous actions of aluminum: potential explanations. [Review].Miner. Electrolyte Metab. 17:233–239.

    Google Scholar 

  48. Morrissey, J., Rothstein, M., Mayor, G. and Slatopolsky, E. (1983) Suppression of parathyroid hormone secretion by aluminum.Kidney Int. 23:699–704.

    Google Scholar 

  49. Parisien, M., Charhon, S. A., Arlot, M., Mainetti, E., Chavassieux, P., Chapuy, M. C. and Meunier, P. J. (1995) Evidence for a toxic effect of aluminum on osteoblasts: a histomorphometric study in hemodialysis patients with aplastic bone disease.J. Bone Miner. Res. 3:259–267.

    Google Scholar 

  50. Coburn, J. W., Norris, K. C. and Nebeker, H. G. (1986) Osteomalacia and bone disease arising from aluminum. [Review].Semin. Nephrol. 6:68–89.

    Google Scholar 

  51. Coburn, J. W. and Norris, K. C. (1986) Diagnosis of aluminum-related bone disease and treatment of aluminum toxicity with deferoxamine. [Review].Semin. Neprhol. 6:12–21.

    Google Scholar 

  52. Norris, K. C., Crooks, P. W., Nebeker, H. G., Hercz, G., Milliner, D. S., Gerszi, K., Slatopolsky, E., Andress, D. L., Sherrard, D. J. and Coburn, J. W. (1985) Clinical and laboratory features of aluminum-related bone disease: differences between sporadic and “epidemic” forms of the syndrome.Am. J. Kidney Dis,6:342–347.

    Google Scholar 

  53. Goodman, W. G. and Duarte, M. E. (1991) Aluminum: effects on bone and role in the pathogenesis of renal osteodystrophy.Mineral & Electrolyte Metabolism 17:221–232.

    Google Scholar 

  54. Vokicevic, S., Krempien, B. and Stavljenic, A. (1987) Effects of 1 alpha, 25- and 24R,25-dihydroxyvitamin D3 on aluminum-induced rickets in growing uremic rats.J. Bone Miner. Res. 2:533–545.

    Google Scholar 

  55. Hartle, J. E., Arthur, J. M., Raymond, J. R. and Quarles, L. D. (1994) Evidence for cation sensing receptor in osteoblasts coupled to G-protein activation and DNA synthesis.J. Bone Miner. Res. (16th Annual Meeting of ASBMR, Kansas City, Missouri)9: sl59 (Abstract).

    Google Scholar 

  56. Wang, S. P., Utrapiromsuk, S., Baylink, D. J. and Lau, K. H. W. (1994) The mitogenic action of low doses of aluminum ion in human bone and skin fibroblasts is associated with an upregulation of the insulin-like growth factor (IGF) regulatory system.J. Bone Miner. Res. (16th Annual Meeting of ASBMR, Kansas City, Missouri)9: s363 (Abstract).

    Google Scholar 

  57. Ott, S. M., Maloney, N. A., Coburn, J. W., Alfrey, A. C., Sherrard, D. J. (1982) The prevalence of bone aluminum deposition in renal osteodystrophy and its relation to the response to calcitriol therapy.N. Engl. J. Med. 307:709–713.

    Google Scholar 

  58. Cournot-Witmer, G., Zingraff, Plachot, J. J., Escaig, F., Lefevre, R., Boumati, P., Bourdeau, A., Garabedian, M., Galle, P., Bourdon, R., Drueke, T. and Balsan, S. (1981) Aluminum localization in bone from hemodialyzed patients: relationship to matrix mineralization.Kidney Int. 20:375–378.

    Google Scholar 

  59. Andress, D. L., Maloney, N. A., Endres, D. B. and Sherrard, D. J. (1986) Aluminum-associated bone disease in chronic renal failure: high prevalence in a long-term dialysis population.J. Bone Miner. Res. 1:391–398.

    Google Scholar 

  60. Hodsman, A. B., Sherrard, D. J., Alfrey, A. C., Ott, S., Brickman, A. S., Miller, N. L., Maloney, N. A. and Coburn, J. W. (1982) Bone aluminum and histomorphometric features of renal osteodystrophy.J. Clin. Endocrinol. Metab. 54:539–546.

    Google Scholar 

  61. Charbon, S. A., Chavassieux, P. M., Chapuy, M. C., Boivin, G. Y. and Meunier, P. J. (1985) Low rate of bone formation with or without histologic appearance of osteomlacia in patients with aluminum intoxication.J. Lab. Clin. Med. 106:123–131.

    Google Scholar 

  62. Parisien, M., Charhon, S. A., Arlot, M., Mainetti, E., Chavassieux, P., Chapuy, M. C. and Meunier, P. J. (1988) Evidence for a toxic effect of aluminum on osteoblasts: a histomorphometric study in hemodialysis patients with aplastic bone disease.J. Bone Miner. Res. 3:259–267.

    Google Scholar 

  63. Sedman, A. B., Alfrey, A. C., Miller, N. L. and Goodman, W. G. (1987) Tissue and cellular basis for impaired bone formation in aluminum-related osteomlacia in the pig.J. Clin. Invest. 79:86–92.

    Google Scholar 

  64. Fanti, P., Combs, T. R., Kindy, M. S., Colombo, G. and Malluche, H. H. (1994) Aluminum affects parathryoid hormone-induced production of osteocalcin without altering expression of osteoclacin messenger ribonucleic acid.J. Bone Miner. Res. (16th Annual meeting of ASBMR, Kansas City, Missouri)9:s226 (Abstract).

    Google Scholar 

  65. Cointry, G. R., Negri, A. L., Azquez, S. O., Zanchetta, J. R. and Ferretti, J. L. (1994) Tomographic and biomechanical effects of aluminum accumulation into rat cortical bone. A mechanostatic interpretation.J. Bone Miner. Res. (16th Annual Meeting of ASBMR, Kansas City, Missouri)9:s377 (Abstract).

    Google Scholar 

  66. Hansour, J. M., Ehrlich, A. and Mansour, T. E. (1983) The dual effects of aluminum as activator and inhibitor of adenylate cyclase in the liver fluke Fasciola hepatica.Biochem. Biophys. Res. Commun. 112:911–918.

    Google Scholar 

  67. Stermweis, P. C. and Gilman, A. G. (1982) Aluminum: a requirement for activation of the regulatory component of adenylate cyclase by fluoride.Proc. Natl. Acad. Sci. USA 79:4888–4891.

    Google Scholar 

  68. Quarles, L. D., Dennis, V. W., Gitelman, H. J., Harrelson, J. M. and Drezner, M. K. (1985) Aluminum deposition at the osteoid-bone interface. An epiphenomenon of the osteomalacic state in vitamin D-deficient dogs.J. Clin. Invest. 75:1441–1447.

    Google Scholar 

  69. Goodman, W. G., Gilligan, J. and Horst, R. (1984) Short-term aluminum administration in the rat. Effects on bone formation and relationship to renal osteomalacia.J. Clin. Invest. 73:171–181.

    Google Scholar 

  70. Verbeelen, D. (1991) Aluminum toxicity [editorial].Acta Clin Belg. 46:63–67.

    Google Scholar 

  71. de Broe, M. E., D'Haese, P. C., Couttenye, M. M., van Landehem, G. F. and Lamberts, L. V. (1993) New insights and strategies in the diagnosis and treatment of aluminum overload in dialysis patients.Nephrol. Dial Transplant 8Suppl. 1:47–50.

    Google Scholar 

  72. Ott, S. M., Feist, E., Andress, D. L., Liu, C. C., Sherrard, D. J., Alfrey, A. C., Slatopolsky, E. and Howard, G. A. (1987) Development and reversibility of aluminum-induced bone lesion in the rat.J. Lab. Clin. Med. 109:40–47.

    Google Scholar 

  73. Bellows, C. G., Aubin, J. E. and Heersche, J. N. M. (1994) Aluminum inhibits both initiation and progression of mineralization in osteoid nodules formed in long term rat calvaria cell cultures.J. Bone Miner. Res. (16th Annual Meeting of ASBMR, Kansas City, Missouri)9:s317 (Abstract).

    Google Scholar 

  74. Quartes, L. D., Gitelman, H. J. and Drezner, M. K. (1988) Induction of de novo bone formation in the beagle. A novel effect of aluminum.J. Clin. Invest. 81:1056–1066.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute for Surgical Research, The National Hospital, Rikshospitalet, Oslo, Norway

    Greg Jablonski, Knut H. Klem & Jan O. Gordeladze

  2. Institute of Medical Biochemistry, University of Oslo, P.O. Box 1112, 0317, Blindern, Oslo, Norway

    Greg Jablonski & Jan O. Gordeladze

  3. Department of Connective Tissue Biology, Institute of Anatomy, DK-8000, Aarhus C, Denmark

    Carl Ch. Danielsen & Lis Mosekilde

Authors
  1. Greg Jablonski
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Knut H. Klem
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Carl Ch. Danielsen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Lis Mosekilde
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jan O. Gordeladze
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Jablonski, G., Klem, K.H., Danielsen, C.C. et al. Aluminium-induced bone disease in uremic Rats: Effect of deferoxamine. Biosci Rep 16, 49–63 (1996). https://doi.org/10.1007/BF01201001

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01201001

Key words

Search

Navigation